Atlas Trials

This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.

Clinical trial NCT00047840 · COMPLETED

Trial details

NCT number
NCT00047840
Sponsor
Genzyme, a Sanofi Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line
Start date
2002-10-01
Enrollment
129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.